vs

Side-by-side financial comparison of BIOHARVEST SCIENCES INC. (BHST) and Recon Technology, Ltd (RCON). Click either name above to swap in a different company.

Recon Technology, Ltd is the larger business by last-quarter revenue ($12.2M vs $8.4M, roughly 1.4× BIOHARVEST SCIENCES INC.).

BioHarvest Sciences Inc. is a biotechnology firm that develops and produces sustainable, high-purity plant-derived bioactive ingredients. It serves the nutraceutical, cosmetics, and pharmaceutical sectors, leveraging proprietary cell cultivation technology to create efficacious natural products without large-scale agricultural farming.

Recon Instruments Inc. was a Canadian technology company that produced smartglasses and wearable displays marketed by the company as "heads-up displays" for sports. Recon's products delivered live activity metrics, GPS maps, and notifications directly to the user's eye. Recon's first heads-up display offering was released commercially in October 2010, roughly a year and a half before Google introduced Google Glass.

BHST vs RCON — Head-to-Head

Bigger by revenue
RCON
RCON
1.4× larger
RCON
$12.2M
$8.4M
BHST

Income Statement — Q3 FY2025 vs Q2 FY2026

Metric
BHST
BHST
RCON
RCON
Revenue
$8.4M
$12.2M
Net Profit
$-832.7K
Gross Margin
60.3%
33.5%
Operating Margin
-14.6%
Net Margin
-6.8%
Revenue YoY
111.0%
Net Profit YoY
70.5%
EPS (diluted)
$-0.09

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BHST
BHST
RCON
RCON
Q4 25
$12.2M
Q3 25
$8.4M
Q2 25
$8.1M
Q1 25
$7.7M
Q4 24
$5.8M
Q3 24
$6.5M
Q2 24
$6.0M
Q4 23
$6.4M
Net Profit
BHST
BHST
RCON
RCON
Q4 25
$-832.7K
Q3 25
Q2 25
Q1 25
Q4 24
$-2.8M
Q3 24
Q2 24
Q4 23
$-3.2M
Gross Margin
BHST
BHST
RCON
RCON
Q4 25
33.5%
Q3 25
60.3%
Q2 25
60.0%
Q1 25
58.2%
Q4 24
31.7%
Q3 24
Q2 24
Q4 23
26.7%
Operating Margin
BHST
BHST
RCON
RCON
Q4 25
-14.6%
Q3 25
Q2 25
Q1 25
Q4 24
-63.9%
Q3 24
Q2 24
Q4 23
-50.4%
Net Margin
BHST
BHST
RCON
RCON
Q4 25
-6.8%
Q3 25
Q2 25
Q1 25
Q4 24
-48.9%
Q3 24
Q2 24
Q4 23
-49.8%
EPS (diluted)
BHST
BHST
RCON
RCON
Q4 25
$-0.09
Q3 25
Q2 25
Q1 25
Q4 24
$-0.31
Q3 24
Q2 24
Q4 23
$-1.16

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BHST
BHST
RCON
RCON
Cash + ST InvestmentsLiquidity on hand
$10.7M
Total DebtLower is stronger
Stockholders' EquityBook value
$66.4M
Total Assets
$77.6M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BHST
BHST
RCON
RCON
Q4 25
$10.7M
Q3 25
Q2 25
Q1 25
Q4 24
$19.9M
Q3 24
Q2 24
Q4 23
$36.0M
Stockholders' Equity
BHST
BHST
RCON
RCON
Q4 25
$66.4M
Q3 25
Q2 25
Q1 25
Q4 24
$66.9M
Q3 24
Q2 24
Q4 23
$60.0M
Total Assets
BHST
BHST
RCON
RCON
Q4 25
$77.6M
Q3 25
Q2 25
Q1 25
Q4 24
$74.2M
Q3 24
Q2 24
Q4 23
$68.1M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BHST
BHST
RCON
RCON
Operating Cash FlowLast quarter
$-1.9M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BHST
BHST
RCON
RCON
Q4 25
$-1.9M
Q3 25
Q2 25
Q1 25
Q4 24
$-1.7M
Q3 24
Q2 24
Q4 23
$-931.0K

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons